Sixth Circuit Tightens FCA Relator Path: “Substantially the Same” Means No Mere Detail, and “Original Source” Requires Pre-Suit Government Disclosure; Novel Theories Still Must Meet Rule 9(b)

1. Introduction

This qui tam appeal sits at the intersection of two recurring False Claims Act (FCA) gatekeeping doctrines: the FCA’s public-disclosure bar and the heightened fraud pleading rule of Federal Rule of Civil Procedure 9(b). Relator Matt Anderson alleged that Saint Elizabeth Medical Center, Inc. and Summit Medical Group, Inc. (collectively, “St. Elizabeth”) orchestrated medically unnecessary kidney dialysis and related procedures and received kickbacks—thereby causing false claims to be submitted to federal and state health programs. He also sought to graft a Kentucky criminal Medicaid-fraud statute into a private civil action via Kentucky’s negligence per se statute.

The central complication was history: years earlier, United States ex rel. Kent v. St. Elizabeth Medical Center (Kent) had publicly alleged a substantially similar dialysis-referral/kickback scheme. The district court dismissed Anderson’s FCA claim as barred by public disclosure and rejected the Kentucky claim as non-cognizable. On appeal, the Sixth Circuit agreed in large part, clarified the limited “freshness” needed to escape the public-disclosure bar, and held that even the only arguably “new” allegation (vascular-treatment work) failed under Rule 9(b).

2. Summary of the Opinion

• Public-disclosure bar: Anderson’s dialysis-related FCA allegations were barred because Kent had already publicly disclosed substantially the same scheme. Anderson’s added details (naming Dr. Shaughnessy; describing EPIC referral workflow; mentioning commercial insurers) did not meaningfully change the fraud “story” for purposes of government notice.
• Vascular-treatment allegations: The court diverged slightly from the district court by recognizing that the vascular-work allegations were not disclosed by Kent and therefore were not barred on “substantially the same” grounds—but held they failed independently because they were not pleaded with the particularity required by Rule 9(b) for FCA claims.
• Original-source exception: Anderson did not qualify as an “original source,” both because the record did not show a voluntary pre-suit disclosure to the Government and because his additions did not “materially add” to the prior public allegations.
• Kentucky law: Kentucky’s negligence per se statute, Ky. Rev. Stat. § 446.070, did not create a qui-tam-like cause of action based on a Medicaid-fraud criminal provision, Ky. Rev. Stat. § 205.8463; Anderson was not within the class the criminal statute was designed to protect.
• Leave to amend: Anderson forfeited any request for amendment by failing to seek leave in the district court.

3. Analysis

3.1. Precedents Cited

A. FCA purpose, structure, and relator “restrictions”

• United States ex rel. Polansky v. Exec. Health Res., Inc., 599 U.S. 419 (2023)
  The court used Polansky to frame qui tam as a congressional choice to enlist private relators while subjecting them to “special restrictions” (including the public-disclosure bar). That framing supports a strict, text-driven application of the bar: relators are helpful, but not meant to recycle public accusations.
• United States v. McNinch, 356 U.S. 595 (1958)
  Cited via Polansky for historical context—the FCA’s Civil War origins and anti-grift purpose. This background bolsters the notion that the FCA targets fraud on the public fisc, while still policing opportunistic enforcement.
• United States ex rel. Rahimi v. Rite Aid Corp., 3 F.4th 813 (6th Cir. 2021)
  Rahimi supplies multiple controlling principles: the public-disclosure bar’s anti-parasitism purpose; the “adds details” insufficiency; and how to assess whether new information “adds value” for government decision-making in the “materially adds” inquiry.
• United States ex rel. Taxpayers Against Fraud v. Gen. Elec. Co., 41 F.3d 1032 (6th Cir. 1994)
  Used to describe relators as “private attorneys-general” and justify why Congress simultaneously incentivizes and constrains private FCA enforcement.

B. Sixth Circuit’s public-disclosure bar framework: notice and “essentially the same scheme”

• United States ex rel. Maur v. Hage-Korban, 981 F.3d 516 (6th Cir. 2020)
  Maur is the opinion’s workhorse. The Sixth Circuit adopts Maur’s three-part test and repeatedly invokes its “key inquiry”: whether prior disclosures could put the government on notice of the alleged fraud. The court also relies on Maur to reject attempts to avoid the bar by adding minor details or peripheral actors.
• United States ex rel. Holloway v. Heartland Hospice, Inc., 960 F.3d 836 (6th Cir. 2020)
  Cited for the idea that the bar filters out suits that “merely feed off” public disclosures and for interpreting how pre-2010 caselaw remains relevant where consistent with the amended text.
• United States ex rel. Poteet v. Medtronic, Inc., 552 F.3d 503 (6th Cir. 2009)
  Cited (through Maur) for the proposition that public disclosure does not require “complete identity ... as to time, place, and manner.” That principle is central to the court’s rejection of Anderson’s “later-developing architecture” characterization.
• United States ex rel. Advocs. for Basic Legal Equal., Inc. v. U.S. Bank, N.A. (ABLE), 816 F.3d 428 (6th Cir. 2016)
  ABLE is used for the “already known in outline” concept (new details do not necessarily create a new scheme) and for the “materially adds” test: whether the new knowledge would affect government decision-making.
• United States ex rel. Gilligan v. Medtronic, Inc., 403 F.3d 386 (6th Cir. 2005)
  Not directly litigated on appeal, but cited to illustrate the low threshold for the first prong: a disclosure need only put the government on notice of the “possibility of fraud.” The opinion signals that the “public disclosure” concept is broad, even though the court ultimately resolves the vascular issue on different prongs.
• United States ex rel. Ibanez v. Brystol-Myers Squibb Co., 874 F.3d 905 (6th Cir. 2017)
  Used in two ways: (1) to describe when renewed conduct after prior government resolution may “materially add” (the “resolved conduct” carveout), and (2) later, as a leading Rule 9(b) case defining what FCA relators must plead (representative false claims or strong inference via specific personal knowledge).

C. Pleading standards and appellate affirmance

• HDC, LLC v. City of Ann Arbor, 675 F.3d 608 (6th Cir. 2012)
  Provides the Rule 12(c) baseline: accept allegations as true and ask whether the complaint states a claim—mirroring Rule 12(b)(6).
• South Side Quarry, LLC v. Louisville & Jefferson Cnty. Metro. Sewer Dist., 28 F.4th 684 (6th Cir. 2022) and United States ex rel. Harper v. Muskingum Watershed Conservancy Dist., 842 F.3d 430 (6th Cir. 2016)
  These cases supply the appellate principle that the Sixth Circuit may affirm on any ground supported by the record. This is critical to the opinion’s structure: even where the court narrows the public-disclosure holding for vascular allegations, it affirms dismissal on Rule 9(b) grounds.
• United States ex rel. Laughlin v. Radiation Therapy Servs., P.S.C., 148 F.4th 791 (6th Cir. 2025)
  Reinforces that FCA claims sound in fraud and therefore must satisfy Rule 9(b). The court then uses Ibanez for the operational standard.

D. Kentucky negligence per se limits and no quasi-qui tam workaround

• Hickey v. Gen. Elec. Co., 539 S.W.3d 19 (Ky. 2018)
  The court relies on Hickey for the three prerequisites to sue under Ky. Rev. Stat. § 446.070, especially the “class of persons” requirement. That requirement defeats Anderson’s attempt to convert a Medicaid-fraud criminal law into a relator-like enforcement mechanism.
• Vanhook v. Somerset Health Facilities, LP, 67 F. Supp. 3d 810 (E.D. Ky. 2014)
  Cited through Hickey for the same three-part framework; supports the district court’s and Sixth Circuit’s conclusion that negligence per se is not a generalized license to privately enforce penal statutes on the Commonwealth’s behalf.

E. Forfeiture of leave-to-amend requests

• Song v. City of Elyria, 985 F.2d 840 (6th Cir. 1993), Siler v. Webber, 443 F. App'x 50 (6th Cir. 2011), and Scottsdale Ins. Co. v. Flowers, 513 F.3d 546 (6th Cir. 2008)
  These cases reflect a consistent Sixth Circuit practice: a party cannot fault a district court for not granting leave to amend that was never requested. The opinion applies that practice to deny Anderson a remand opportunity to re-plead.

3.2. Legal Reasoning

A. “Substantially the same” is a notice-based, scheme-level comparison—not a detail-counting exercise

The Sixth Circuit’s analysis underscores that the public-disclosure bar is not defeated by incremental specificity. The comparison is functional: could the earlier disclosure have put the government on notice of the fraud alleged? By treating Anderson’s “EPIC system” allegation and the naming of “Dr. Shaughnessy” as mere details about the already-disclosed dialysis scheme, the court reinforces a scheme-centric approach: if the core actors and the core fraudulent mechanics are the same, cosmetic elaborations do not create a new FCA case.

The opinion also makes an important practical point: adding allegations that do not expand FCA liability (e.g., billing “commercial insurers”) cannot serve as an escape hatch from the bar. Otherwise, relators could launder a barred FCA theory by pairing it with legally irrelevant facts.

B. “Original source” requires both process (pre-suit government disclosure) and substance (material addition)

The court reads the “original source” exception as a two-part safeguard, not a free-form fairness doctrine. Even if a relator believes they have improved the government’s picture, the statute requires a voluntary disclosure to the government before filing. On the record presented, Anderson did not show he provided information to the government pre-suit, which is independently fatal.

Substantively, the court treats “materially adds” as a “changes the government’s decision-making” standard (from ABLE and Rahimi). In that framing, easily discoverable implementation details (a particular software system; a particular physician’s name) generally do not “add value” in a way likely to alter enforcement appetite when the government already had the scheme’s broad contours.

The opinion also narrows the “renewed fraud after resolution” pathway. It notes that “removed from resolved conduct” reasoning has force where the government intervened or otherwise resolved the earlier scheme, making recurrence genuinely surprising and therefore valuable to report. Where the government did not intervene and the prior action was dismissed, the mere passage of years does not itself create “material” new information.

C. Novel allegations still must satisfy Rule 9(b): four sentences are not an FCA case

Having recognized that the vascular-treatment allegations were not “substantially the same” as Kent, the court immediately applies the separate fraud-pleading constraint: FCA claims must plead a representative false claim actually submitted or facts supporting a strong inference of submission based on specific personal knowledge (Ibanez). Anderson’s vascular allegations—ownership percentage, “automatic scheduling,” and a couple of procedure examples— lacked any representative claim, billing detail, patient example, time frame, or personal-knowledge basis. The court treats this as quintessential Rule 9(b) insufficiency: allegations of suspicious healthcare economics are not pleaded fraud without claim-level particulars.

D. Kentucky negligence per se does not create a qui tam surrogate

Anderson’s Kentucky theory attempted to translate public injury (harm to Medicaid funds) into a private cause of action by invoking Ky. Rev. Stat. § 446.070 (“any statute”) and using Ky. Rev. Stat. § 205.8463 as the violated statute. The Sixth Circuit’s reasoning is straightforward and limiting: Kentucky requires the plaintiff to be within the class the statute intends to protect. The Medicaid-fraud criminal provision protects the Commonwealth’s medical assistance programs from fraudulent claims—not whistleblowers like Anderson. That conclusion blocks a common litigant strategy: using negligence per se as an all-purpose vehicle to privately enforce penal statutes.

3.3. Impact

A. Stronger screening of “follow-on” FCA suits in the Sixth Circuit

The opinion strengthens defendants’ ability to dispose early of FCA suits that track a prior qui tam complaint by emphasizing: (1) a notice-based “substantially the same” test, (2) skepticism toward “new details,” and (3) an unwillingness to treat non-FCA-relevant allegations (commercial insurer billing) as differentiators. Future relators in the Sixth Circuit should expect that once a comparable scheme has been publicly pleaded, later pleadings must either (i) genuinely change the scheme’s core mechanics/actors or (ii) satisfy the original-source pathway with both required disclosures and truly value-adding new information.

B. Practical elevation of pre-suit disclosure proof

The opinion’s handling of the “voluntarily provided the information to the Government before filing” requirement signals an evidentiary vulnerability: relators should be prepared to demonstrate pre-suit disclosures (dates, content, method, recipient agency) or risk losing the original-source exception. The court treats the absence of record support as dispositive, not as a curable technicality.

C. Rule 9(b) remains a separate choke point even for “new” fraud theories

The court’s vascular-treatment discussion is a cautionary template: escaping the public-disclosure bar does not get a relator to discovery unless the pleading contains the “who, what, when, where, and how” of false claims submission. Healthcare fraud allegations often describe referral pressure and ownership incentives; this opinion insists those narratives must connect to claim submission with particularity.

D. Kentucky law: limited avenues for private enforcement of Medicaid-fraud concepts

By rejecting the negligence per se workaround, the opinion narrows the prospects for plaintiffs to create quasi-qui tam state claims absent explicit legislative authorization. Litigants alleging harm to Kentucky’s Medicaid fisc will generally need either (i) a statute providing a private cause of action, or (ii) a concrete personal injury that places them in the protected class for negligence per se purposes.

4. Complex Concepts Simplified

• False Claims Act (FCA): A federal law imposing liability for knowingly submitting (or causing submission of) false claims for government money. In healthcare, that often means claims to Medicare/Medicaid for services that are not reimbursable (e.g., not medically necessary) or that are tainted by illegal kickbacks.
• Qui tam / “relator”: A private person can sue on the government’s behalf and share in any recovery, but must satisfy special limitations.
• Public-disclosure bar: If substantially the same fraud allegations were already publicly disclosed (including in another qui tam case), the later suit is dismissed unless the relator qualifies as an “original source.”
• “Substantially the same”: Not identical wording. The test asks whether the earlier disclosure could have put the government on notice of the fraud’s essential scheme; adding minor details usually does not help.
• Original source: A relator who either disclosed information to the government before the public disclosure, or who has knowledge that materially adds and who provided it to the government before filing suit. In practice, this is both a timing requirement and a significance requirement.
• Rule 9(b): A heightened pleading rule for fraud. In FCA cases, the relator generally must identify representative false claims actually submitted (or plead facts creating a strong inference of submission based on specific personal knowledge).
• Negligence per se (Ky. Rev. Stat. § 446.070): A Kentucky doctrine allowing a civil suit for violating a statute only when the plaintiff is within the protected class and suffered the type of injury the statute aims to prevent—so it is not a general tool to privately enforce criminal laws.

5. Conclusion

The Sixth Circuit’s decision delivers a structured message to FCA relators: the courthouse door narrows dramatically once a comparable fraud narrative is already in the public domain. “New” names, internal workflow descriptions, and other implementation details will not typically avoid the public-disclosure bar, and the original-source exception is unavailable without both a pre-suit government disclosure and a genuinely material contribution. Even where a relator alleges a distinct fraud component (here, vascular-treatment work), the complaint must still satisfy Rule 9(b) with claim-linked particulars.

On the state-law side, the opinion confirms that Kentucky’s negligence per se statute does not create a qui tam analog for Medicaid fraud; absent explicit legislative authorization, private plaintiffs cannot position themselves as the Commonwealth’s enforcement surrogate merely by citing a penal statute.